학술논문

Pre-eclampsia: Universal Screening or Universal Prevention for Low andMiddle-Income Settings?
Document Type
article
Source
Revista Brasileira de Ginecologia e Obstetrícia. January 2021 43(1)
Subject
preeclampsia
screening
prevention
aspirin
calcium
Language
English
ISSN
0100-7203
Abstract
Pre-eclampsia (PE) is a severe disorder that affects up to 8% of all pregnancies and represents an important cause of maternal and perinatal morbidity and mortality. The screening of the disease is a subject of studies, but the complexity and uncertainties regarding its etiology make this objective a difficult task. In addition, the costs related to screening protocols, the heterogeneity of the most affected populations and the lack of highly effective prevention methods reduce the potential of current available algorithms for screening. Thus, the National Specialized Commission of Hypertension in Pregnancy of the Brazilian Association of Gynecology and Obstetrics Federation (Febrasgo, in the Portuguese acronym) (NSC Hypertension in Pregnancy of the Febrasgo) considers that there are no screening algorithms to be implemented in the country to date and advocates that Aspirin and calcium should be widely used.